Advanced search
Publication Cover
International Journal of Cardiovascular Interventions Volume 4, 2001 - Issue 1
Journal homepage
3
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Selective use of abciximab in coronary stenting: overall outcomes can still be equivalent to those in the EPISTENT treatment group

DJA Price, PG Campbell, AGC Sutton, ED Grech, A Davies, JA Hall, MA de Belder
Pages 15-20 | Published online: 10 Jul 2009

  • Schomig A, Neumann FJ, Kastrati A, et al. A randomised comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med 1996; 334: 1084-1089.
  • Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three antithrombotic drug regimens after coronary artery stenting. N Engl J Med 1998; 339: 1665-1671.
  • Stables RH. Routine use of abciximab in coronary stenting? Lancet 1998; 352: 81-82.
  • Flachskampf F, Ellis SG, Simpson DE, Grines CL, Curzen N, Rothman MT. The wide use of IIb/IIIa inhibitors in interventional cardiology -- is it justified? Int J Cardiovasc Intervent 1999; 2: 61-70.
  • de Beider MA. The economics of GP IIb/IIIa inhibition in percutaneous coronary intervention. Acute Coron Syndromes 1998; 1: 132-137.
  • Weintraub WS, Thompson TD, Culler S, et al. Targeting patients undergoing angioplasty for thrombus inhibition. Circulation 2000; 102: 392-398.
  • Topol EJ et al for the EPISTENT Investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet 1998; 352: 87-92.
  • Califf RM, et al for the EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor inhibitor in high risk coronary angioplasty. N Engl J Med 1994; 330: 956-961.
  • Ryan TJ, Faxon DP, Gunnar RM, et al. Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1988; 78: 486-502.
  • Lincoff AM, Califf RM, Moliterno DJ, et al. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. N Engl J Med 1999; 341: 319-327.
  • Ellis SG, Bates ER, Schaible T, Weisman HF, Pitt B, Topol EJ. Prospects for the use of antagonists to the platelet glycoprotein IIb/IIIa receptor to prevent post-angioplasty restenosis and thrombosis. J Am Coll Cardiol 1991; 17(suppl B): 89B-95B.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.